Ravi Prakash Rao
About Ravi Prakash Rao
Ravi Prakash Rao is an Assistant Manager at Fresenius Kabi in Bad Homburg, Germany, with over eight years of experience in clinical strategy and regulatory compliance. He has a background in pharmacology and has held various research positions within the Fresenius Kabi organization since 2010.
Work at Fresenius Kabi
Ravi Prakash Rao has been employed at Fresenius Kabi since 2016, serving as an Assistant Manager in Bad Homburg, Hessen, Germany. In this role, he coordinates with various functions and departments to develop clinical strategies and assess feasibility for product development. His responsibilities include ensuring compliance with both internal documentation standards and external regulatory guidelines. He has also evaluated safety updates for submission to the Corporate Labeling Committee and resolved medical queries from regulatory agencies and global marketing teams.
Previous Experience in Oncology Research
Before his current position, Ravi Prakash Rao worked at Fresenius Kabi Oncology Limited in India as a Senior Research Scientist-i from 2010 to 2012. He later returned to Fresenius Kabi in Germany, where he held the position of Senior Research Scientist-ii from 2013 to 2015. His experience in oncology research has contributed to his expertise in clinical strategy and regulatory compliance.
Education and Expertise
Ravi Prakash Rao holds a Bachelor of Pharmacy degree from Chaudhary Charan Singh University, which he completed from 1999 to 2003. He furthered his education in pharmacology at the Birla Institute of Technology, Mesra, from 2004 to 2006. Additionally, he studied pharmacology and pharmacy at Delhi University from 2007 to 2010. This educational background has equipped him with the knowledge necessary for his roles in clinical strategy and product development.
Regulatory Compliance and Documentation
In his role at Fresenius Kabi, Ravi Prakash Rao has been responsible for ensuring that documentation complies with both internal and external regulatory standards. He has prepared documents in accordance with the Pediatric Research Equity Act and the Pregnancy and Lactation Labeling Rule. His work includes providing scientific justifications for various queries related to cytotoxicity information and administration routes, demonstrating his proficiency in regulatory documentation.